Associate Director, US HCP Marketing, Derm-GI Lead

How will your role help us transform hope into reality?

As Associate Director of US HCP Marketing, Derm/GI and Diagnostic Strategy Lead for AYVAKIT (avapritinib), you will be at the forefront of how dermatologists and gastroenterologists (GI), along with other frontline specialists, recognize and diagnose Indolent Systemic Mastocytosis (ISM). You will bring a strategic, insight-driven lens to the complex, multi-specialty diagnostic journey, translating heterogeneous, symptom-driven presentations into clear, practical tools and narratives that fit into real-world Derm and GI practice.

By understanding how these clinicians think about chronic skin, GI, and other allergy-type symptoms, you will help raise suspicion for ISM earlier, prompt appropriate workups and referrals, and ultimately enable more patients to reach a therapy that targets the underlying driver of disease.

In this role, you will lead US HCP marketing strategy and execution for Derm and GI in ISM, while also serving as the diagnostic champion across all specialties that are part of ISM patient diagnostic journey, including Allergy/Immunology (A/I) and Hematology/Oncology (H/O). You will serve as the voice of Derm, GI, and the cross-specialty diagnostic pathway within the organization, partnering closely with the H/O, A/I and Med Ed HCP leads, Field Sales, Medical, Precision Medicine, Patient Marketing, Omnichannel Marketing, Commercial Operations, BI&A, and other collaborators to create a cohesive experience that drives earlier suspicion, diagnosis and referral for ISM.

You will join a high-performing, collaborative HCP marketing team at the center of the ISM lifecycle strategy for AYVAKIT at Blueprint Medicines, a Sanofi Company. In this team, you will have the opportunity to innovate in an under diagnosed rare disease, shape new engagement strategies with Derm and GI, and work alongside colleagues who share a commitment to our Patient First mindset.

This role will report to the HCP Team Lead.

• Lead HCP marketing strategy and execution for AYVAKIT in the Derm and GI specialties in ISM, with a primary focus on driving suspicion and diagnosis, aligned with brand objectives
• Own the cross-specialty diagnostic strategy for ISM across Derm, GI, A/I, and H/O, partnering closely with the H/O and A/I HCP leads to ensure consistent diagnostic messaging and tools, and a coherent story from suspicion through diagnosis
• Translate insights from Derm, GI, and other frontline specialists involved in ISM suspicion and diagnosis into clear positioning, core messaging, and educational campaigns that drive earlier suspicion, appropriate workup, and referral for ISM
• Map and continuously refine the ISM diagnostic journey across specialties, identifying key barriers and developing targeted initiatives to shorten time to diagnosis
• Support diagnostic-focused, Derm and GI market research in partnership with Business Insights & Analytics (BI&A) to generate actionable insights that inform strategy and maximize the impact of educational efforts
• Partner with the Omnichannel Lead to design and optimize integrated digital and omnichannel journeys that ensure diagnostic-focused ISM educational content effectively reaches and engages Derm, GI, and other frontline HCPs involved in suspicion and diagnosis
• Collaborate with the Medical Education Lead to shape and support peer-to-peer engagement on recognition and diagnosis of ISM, including speaker programs, educational events, and congress strategy and execution for Derm, GI, and cross-specialty diagnostic audiences
• Develop high-impact educational content for Derm, GI, and cross-specialty diagnostic needs, and lead review with Medical, Legal, Regulatory, and Compliance to ensure scientific accuracy and full compliance
• Work with Field Sales to understand Derm, GI and diagnostic-journey needs, refine messaging, and create field tools that drive effective pull-through and support earlier identification and referral of appropriate ISM patients
• Manage agency and vendor partners, providing clear strategic direction and overseeing timelines, budgets, and quality of deliverables
• Travel approximately 20% to 25% of the…